Department of Medical and Surgery Sciences, Clinical Surgery Unit, University of Catanzaro "Magna Graecia" Medical School, Viale Europa, Germaneto, 88100 Catanzaro, Italy ; Surgery Unit, National Cancer Research Centre, Giovanni Paolo II, 70100 Bari, Italy.
Department of Medical and Surgery Sciences, Clinical Surgery Unit, University of Catanzaro "Magna Graecia" Medical School, Viale Europa, Germaneto, 88100 Catanzaro, Italy.
Gastroenterol Res Pract. 2014;2014:951957. doi: 10.1155/2014/951957. Epub 2014 Jun 4.
Background. Literature data suggest that cells such as mast cells (MCs), are involved in angiogenesis. MCs can stimulate angiogenesis by releasing of several proangiogenic cytokines stored in their cytoplasm. In particular MCs can release tryptase, a potent in vivo and in vitro proangiogenic factor. Nevertheless few data are available concerning the role of MCs positive to tryptase in primary pancreatic cancer angiogenesis. This study analyzed MCs and angiogenesis in primary tumour tissue from patients affected by pancreatic ductal adenocarcinoma (PDAC). Method. A series of 31 PDAC patients with stage T2-3N0-1M0 (by AJCC for Pancreas Cancer Staging 7th Edition) was selected and then underwent surgery. Tumour tissue samples were evaluated by means of immunohistochemistry and image analysis methods in terms of number of MCs positive to tryptase (MCDPT), area occupied by MCs positive to tryptase (MCAPT), microvascular density (MVD), and endothelial area (EA). The above parameters were related to each other and to the main clinicopathological features. Results. A significant correlation between MCDPT, MCAPT, MVD, and EA group was found by Pearson's t-test analysis (r ranged from 0.69 to 0.81; P value ranged from 0.001 to 0.003). No other significant correlation was found. Conclusion. Our pilot data suggest that MCs positive to tryptase may play a role in PDAC angiogenesis and they could be further evaluated as a novel tumour biomarker and as a target of antiangiogenic therapy.
背景。文献资料表明,肥大细胞(MCs)等细胞参与血管生成。MCs 可以通过释放储存在细胞质中的几种促血管生成细胞因子来刺激血管生成。特别是 MCs 可以释放类胰蛋白酶,这是一种有效的体内和体外促血管生成因子。然而,关于对类胰蛋白酶呈阳性的 MCs 在原发性胰腺癌血管生成中的作用的数据很少。本研究分析了原发性胰腺癌患者肿瘤组织中的 MCs 和血管生成。方法。选择了 31 例 T2-3N0-1M0 期(根据 AJCC 胰腺癌分期第 7 版)的胰腺导管腺癌(PDAC)患者,然后进行手术。通过免疫组织化学和图像分析方法评估肿瘤组织样本中对类胰蛋白酶呈阳性的 MCs(MCDPT)数量、对类胰蛋白酶呈阳性的 MCs 所占面积(MCAPT)、微血管密度(MVD)和内皮面积(EA)。将上述参数相互关联,并与主要临床病理特征相关联。结果。通过 Pearson's t 检验分析发现,MCDPT、MCAPT、MVD 和 EA 组之间存在显著相关性(r 范围从 0.69 到 0.81;P 值范围从 0.001 到 0.003)。没有发现其他显著相关性。结论。我们的初步数据表明,对类胰蛋白酶呈阳性的 MCs 可能在 PDAC 血管生成中发挥作用,它们可以进一步评估为新型肿瘤标志物和抗血管生成治疗的靶点。